Compugen Ltd. (CGEN) vs Nautilus Biotechnolgy, Inc. (NAUT)

A side-by-side comparison of Compugen Ltd. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGEN vs NAUT

growth of $100 · dividends reinvested · last 6y
CGEN -85.9% (-27.8%/yr)NAUT -82.1% (-24.9%/yr)NAUT compounded faster over this window
050100150200Start $100202120222023202420252026$14$18
CGEN NAUT

CGEN vs NAUT: by the numbers

  • •NAUT is the larger company ($249M vs $216M market cap).
  • •CGEN is profitable (47.55% net margin) while NAUT runs a net loss (-29747.89%).

Metrics side by side

Valuation

MetricCGENNAUT
P/E ratio6.07N/A
P/S ratio2.911307.92
P/B ratio2.431.90

Profitability

MetricCGENNAUT
Gross margin86.89%0.00%
Operating margin40.94%0.00%
Net margin47.55%-29747.89%
ROE39.66%-43.11%
ROIC26.14%-40.52%

Growth (annualized)

MetricCGENNAUT
Revenue CAGR (5Y)105.91%N/A
Total return CAGR (5Y)-18.39%-20.56%

Frequently asked

Is CGEN or NAUT more profitable?
CGEN runs the higher net margin — CGEN at 47.55% versus NAUT at -29747.89%.
How have CGEN and NAUT total returns compared?
Over the past 5 years, CGEN delivered -18.39% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.